Heron Pharmaceutical Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
332
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
10
Heron Pharmaceutical General Information
Description
Developer and provider of pharmaceutical R&D services and specialty drug development solutions designed for the discovery and optimization of innovative, modified, and generic medicines. The company provides integrated preclinical development services-including API and formulation process development, quality and stability studies-as well as technology transfer and consulting, enabling biopharma clients to accelerate drug development and regulatory readiness.
Contact Information
Website
www.heronpharma.cnCorporate Office
- Building 10, North District, Life Science and Technology Town
- No. 568, Longmian Avenue, Jiangning District
- Nanjing, Jiangsu 211100
- China
Corporate Office
- Building 10, North District, Life Science and Technology Town
- No. 568, Longmian Avenue, Jiangning District
- Nanjing, Jiangsu 211100
- China
Heron Pharmaceutical Timeline
Heron Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Heron Pharmaceutical Patents
Heron Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026214758-A1 | Compound having synergistic analgesic effect, composition and use | Pending | 11-Apr-2025 | ||
| WO-2023115511-A1 | Arylpropionic acid derivative and emulsion preparation thereof | Inactive | 24-Dec-2021 | ||
| EP-4134362-A1 | Ibuprofen ester derivative and emulsion formulation thereof | Active | 29-Jun-2021 | ||
| EP-4134362-A4 | Ibuprofen ester derivative and emulsion formulation thereof | Active | 29-Jun-2021 | ||
| EP-4134362-B1 | Ibuprofen ester derivative and emulsion formulation thereof | Active | 29-Jun-2021 | C07C69/96 |
Heron Pharmaceutical Signals
Heron Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Heron Pharmaceutical FAQs
-
When was Heron Pharmaceutical founded?
Heron Pharmaceutical was founded in 2013.
-
Where is Heron Pharmaceutical headquartered?
Heron Pharmaceutical is headquartered in Nanjing, China.
-
What is the size of Heron Pharmaceutical?
Heron Pharmaceutical has 332 total employees.
-
What industry is Heron Pharmaceutical in?
Heron Pharmaceutical’s primary industry is Drug Discovery.
-
Is Heron Pharmaceutical a private or public company?
Heron Pharmaceutical is a Private company.
-
What is the current valuation of Heron Pharmaceutical?
The current valuation of Heron Pharmaceutical is .
-
What is Heron Pharmaceutical’s current revenue?
The current revenue for Heron Pharmaceutical is .
-
How much funding has Heron Pharmaceutical raised over time?
Heron Pharmaceutical has raised $68.6M.
-
Who are Heron Pharmaceutical’s investors?
Hubei Zhenghan Investment (Daye), Jiangsu Zhonggao Private Equity Fund Management, Qualifind Medical, Guosheng (Jiangsu) Venture Capital, and Xi'an Manareco are 5 of 8 investors who have invested in Heron Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process